论文部分内容阅读
目的观察与评估倍他乐克治疗慢性充血性心力衰竭的疗效。方法61例心脏轻、中度慢性充血性心力衰竭的患者随机分为两组。对照组接受常规抗心力衰竭治疗;治疗组在常规治疗基础上加服倍他乐克,共治疗12周。结果治疗组:显效8例,显效率25.8%,有效20例,有效率64.5%,无效3例,总有效率90.3%。对照组:显效5例,显效率16.7%,有效17例,有效率56.7%,无效7例,总有效率73.3%。治疗组总有效率明显高于对照组,差异有显著性(P<0.05)。结论心力衰竭常规治疗基础上加服倍他乐克对改善心力衰竭症状疗效显著。
Objective To observe and evaluate the efficacy of metoprolol in the treatment of chronic congestive heart failure. Methods Sixty-one patients with mild and moderate chronic congestive heart failure were randomly divided into two groups. The control group received routine anti-heart failure treatment; the treatment group was given Betaloc on the basis of routine treatment for a total of 12 weeks. Results The treatment group: 8 cases markedly effective, markedly effective rate of 25.8%, effective in 20 cases, the effective rate was 64.5%, 3 cases were ineffective, the total effective rate was 90.3%. Control group: 5 cases markedly effective, effective rate of 16.7%, effective in 17 cases, effective rate was 56.7%, ineffective in 7 cases, the total effective rate was 73.3%. The total effective rate of the treatment group was significantly higher than that of the control group, the difference was significant (P <0.05). Conclusions The conventional treatment of heart failure plus Betaloc can improve the symptoms of heart failure significantly.